Page last updated: 2024-09-04

moxifloxacin and Infection, Mycobacterium avium-intracellulare

moxifloxacin has been researched along with Infection, Mycobacterium avium-intracellulare in 24 studies

Research

Studies (24)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (33.33)	29.6817
2010's	10 (41.67)	24.3611
2020's	6 (25.00)	2.80

Authors

Authors	Studies
Fukushima, K; Higashiyama, Y; Hirakata, Y; Kohno, S; Kohno, Y; Miyazaki, Y; Ohno, H; Yanagihara, K	1
Deshpande, D; Gumbo, T; Hall, GS; Leff, R; Meek, C; Srivastava, S	1
Bader, JS; Danchik, C; Hoover, L; Karakousis, PC; Matern, WM; Parker, H	1
He, W; Li, Y; Liu, C; Ma, A; Qiu, Q; Zhao, Y	1
Chong, YP; Jo, KW; Lee, HJ; Park, YE; Shim, TS	1
Alcaide, F; Andres, S; Aubry, A; Benmansour, H; Boarbi, S; Cambau, E; Chryssanthou, E; Cirillo, DM; Fernström, L; Fitzgibbon, MM; Fröberg, G; Giske, CG; Hyyryläinen, HL; Kahlmeter, G; Keller, PM; Machado, D; Maurer, FP; Mengshoel, AT; Mok, S; Nadarajan, D; Schön, T; Svensson, E; Turnidge, J; van Ingen, J; Viveiros, M; Werngren, J	1
Faksri, K; Hinwan, Y; Kaewprasert, O; Sirichoat, A	1
Chang, CL; Chen, LC; Chien, JY; Hsueh, PR; Yu, CJ	1
Chen, HC; Huang, CC; Huang, WC; Wu, MF	1
Cohen, L; Guarner, J; Hunt, WR	1
Deshpande, D; Gumbo, T; Lee, PS; Pasipanodya, JG; Srivastava, S	1
Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Ki, CS; Kim, SY; Koh, WJ; Kwon, OJ; Lee, NY; Moon, SM; Shin, SH; Shin, SJ; Suh, GY; Yoo, IY	1
Fujiuchi, S; Hasegawa, N; Higuchi, T; Ito, Y; Kikuchi, T; Kurashima, A; Niimi, A; Ogawa, K; Suzuki, K; Uchiya, KI; Watanabe, A; Yamaba, Y	1
Hong, G; Jeon, K; Jeong, BH; Kim, CK; Kim, SY; Koh, WJ; Kwon, OJ; Lee, SH; Park, HY; Shin, SJ	1
Jo, KW; Kim, DS; Kim, S; Kim, WS; Lee, JY; Lee, SD; Shim, TS	1
Amoroso, A; Britt, EJ; Burke, AP; Franco, M; Reed, RM	1
Deshpande, D; Gumbo, T	1
Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS	1
Aralar, P; Bermudez, LE; Inderlied, CB; Kolonoski, P; Reynolds, R; Young, LS	1
Bermudez, LE; Kolonoski, P; Petrofsky, M; Reynolds, R; Seitz, LE; Wu, M; Young, LS	1
Bermudez, LE; Carter, G; Young, LS	1
Käser, L; Naumann, UK; Steurer-Stey, C; Vetter, W	1
Aralar, P; Bermudez, LE; Inderlied, CB; Kolonoski, P; Petrofsky, M; Wu, M; Young, LS	1
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G	1

Reviews

1 review(s) available for moxifloxacin and Infection, Mycobacterium avium-intracellulare

Article	Year
Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium. Future microbiology, 2011, Volume: 6, Issue:4 Topics: Anti-Bacterial Agents; Aza Compounds; Ethambutol; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Treatment Outcome	2011

Other Studies

23 other study(ies) available for moxifloxacin and Infection, Mycobacterium avium-intracellulare

Article	Year
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Animals; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Japan; Levofloxacin; Liver; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Ofloxacin; Quinolines; Spleen	2007
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Area Under Curve; Aza Compounds; Cell Line; Colony Count, Microbial; Fluoroquinolones; Half-Life; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Protein Binding; Quinolines	2010
Genetic Determinants of Intrinsic Antibiotic Tolerance in Mycobacterium avium. Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2 Topics: Anti-Bacterial Agents; Clarithromycin; DNA Transposable Elements; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Humans; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin	2021
Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China. Journal of global antimicrobial resistance, 2022, Volume: 31 Topics: Amikacin; Clarithromycin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium tuberculosis; Rifabutin	2022
Clinical Outcome with Standard Regimen plus Clofazimine or Moxifloxacin in Cavitary Mycobacterium avium Complex Pulmonary Disease. Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12 Topics: Anti-Bacterial Agents; Clofazimine; Humans; Lung Diseases; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies	2022
Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium abscessus; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria	2023
Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. PloS one, 2023, Volume: 18, Issue:11 Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Phylogeny; Thailand	2023
Different clinical features of patients with pulmonary disease caused by various Mycobacterium avium-intracellulare complex subspecies and antimicrobial susceptibility. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 98 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Taiwan; Young Adult	2020
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin	2018
A novel presentation of Mycobacterium avium complex in a recipient of a lung transplant: a case report. Journal of medical case reports, 2017, Aug-28, Volume: 11, Issue:1 Topics: Aged; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Graft Rejection; Humans; Immunosuppressive Agents; Lung; Lung Transplantation; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prednisone; Pulmonary Fibrosis; Rifampin; Tacrolimus; Tomography, X-Ray Computed; Tuberculosis, Pulmonary	2017
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease. The Journal of antimicrobial chemotherapy, 2017, Sep-01, Volume: 72, Issue:suppl_2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Fluoroquinolones; Humans; Lung Diseases; Macrophages; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Organophosphates; Oxazoles; Rifabutin; THP-1 Cells	2017
Mutations in Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Antitubercular Agents; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	2018
Moxifloxacin resistance and genotyping of Mycobacterium avium and Mycobacterium intracellulare isolates in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:12 Topics: Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Japan; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Mutation; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection	2019
Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Ethambutol; Female; Fluoroquinolones; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Rifampin; Sputum	2013
Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:10 Topics: Aged; Anti-Bacterial Agents; Clofazimine; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Linezolid; Lung Diseases; Male; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retreatment; Retrospective Studies; Rifabutin; Treatment Failure	2014
Pulmonary mycobacterial spindle cell pseudotumor in a lung transplant patient: progression without therapy and response to therapy. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3 Topics: Aged; Anti-Bacterial Agents; Azithromycin; Disease Progression; Ethambutol; Female; Fluoroquinolones; Humans; Immunocompromised Host; Lung; Lung Transplantation; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Treatment Outcome	2015
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease. The Journal of infectious diseases, 2003, Jun-15, Volume: 187, Issue:12 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; Aza Compounds; Clarithromycin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mefloquine; Mice; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines	2003
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in mice. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:8 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Colony Count, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Liver; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Spleen; Thioacetazone	2003
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:9 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Colony Count, Microbial; Drug Interactions; Drug Therapy, Combination; Female; Fluoroquinolones; Liver; Mefloquine; Mice; Mice, Inbred C57BL; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Quinolines; Spleen; Thioacetazone	2004
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Biofilms; Clarithromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines	2004
[Brochiectasis (in the adult)]. Praxis, 2007, Jun-13, Volume: 96, Issue:24 Topics: Adult; Aged; Aza Compounds; Bronchiectasis; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Immunization, Passive; Immunoglobulin M; Male; Moxifloxacin; Mycobacterium avium-intracellulare Infection; Paraproteinemias; Quinolines; Rifabutin; Tomography, X-Ray Computed; Waldenstrom Macroglobulinemia	2007
Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:1 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Azithromycin; Drug Interactions; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Quinolines; Rifabutin	2001
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine. The Journal of infection, 2002, Volume: 44, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines	2002